Molecular Devices introduces ion channel screening system
Molecular Devices has introduced the IonWorks Quattro, which claims to have four times the throughput capability over its predecessor the IonWorks HT.
Molecular Devices has introduced the IonWorks Quattro, which claims to have four times the throughput capability over its predecessor the IonWorks HT.
US scientists have demonstrated that by knocking out two key signals in liver cells causes diabetes. These findings pave the way for drug strategies to boost these two different signals and treat the different metabolic components in sufferers.
A silicon-based drug delivery system, developed by Australian nanotechnology company pSivida, has passed an important proof-of-concept hurdle in a clinical trial involving patients with inoperable liver cancer.
The UK education system is failing to provide sufficient high calibre scientists needed for the research-based pharmaceutical industry. The concern is that financial targets have meant university science departments becoming increasingly vulnerable to...
Thomson Scientific & Healthcare has launched a new service to allow pharmaceutical companies to quickly create and modify drug labels that comply with new US Food and Drug Administration guidance due to come into play this year.
Israeli drug and active pharmaceutical ingredients (API) company Teva has reported a sharp increase in sales in 2004, helped in part by last year's $3.4bn (€2.6bn) acquisition of Sicor.
The first documented case of drug resistant HIV has prompted calls to step up HIV drug research after the victim developed full-blown AIDS in just three months.
As the cost of commercialising drugs continues to spiral, results from a trial evaluating the concept of human microdosing is set to offer great potential in drug development. The pharmaceutical industry is placing importance in finding ways of...
Two US companies have teamed up to market a separation technology that could improve the yield, purity and length of oligonucleotide sequences.